Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
157.60    3.80 (2.47%)
Bid:
157.60
Ask:
158.00
Spread: 0.40 (0.254%)
Market Cap: £385.03m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Trading Update

19 Oct 2023 07:00

RNS Number : 5905Q
Sabre Insurance Group PLC
19 October 2023
 

19 October 2023

Sabre Insurance Group plc

 

Trading Update

Strong premium growth and healthy capital position

 

Sabre Insurance Group plc (the "Group" or "Sabre"), one of the UK's leading motor insurance underwriters, today provides an update on trading for the period from 1 July 2023 to 30 September 2023.

Financial highlights

Nine months ended

30 September

Year ended

31 December

 2023

2022

% change

2022

Gross written premium

£162.2m

£135.7m

19.5%

£171.3m

Gross written premium - Motor Vehicle

£140.5m

£105.2m

33.6%

£134.9m

Gross written premium - Motorcycle

£10.7m

£20.9m

(48.8%)

£23.1m

Gross written premium - Taxi

£11.0m

£9.6m

14.6%

£13.3m

Post-dividend solvency capital ratio

191%

163%

154%

Business highlights for the first nine months of 2023

? Strong performance from our core Motor Vehicle book

? Gross written premiums ('GWP') up 34% year-to-date and up 61% versus Q3 2022

? In recent weeks, premium run-rate has been over 80% up year-on-year

? Increase in policy count, while maintaining continued focus on profitability as a target and volume as an output. Core Motor Vehicle policy count 222k at 30 September 2023 (30 June 2023: 211k)

? Significant rate increases mitigating the impact of claims inflation and ensuring margins return towards historical levels for business written in recent months

? Increase in solvency capital ratio reflects return towards historical levels of underwriting profitability on core Motor Vehicle business and profitable growth

? Good performance from Motorcycle book

? Ongoing focus on margin over volume - with rate increases expected to drive improved loss ratio performance for 2023 vs 2022

? Policy count and premium growth impacted by the cessation of trading with MCE Insurance, offset by increase in sales through our alternate channel. Motorcycle policy count 45k at 30 September 2023 (30 June 2023: 48k)

? Taxi book performance improving as planned

? Taxi market remains challenging, significant underwriting actions starting to show improved loss ratio performance but have reduced premium run-rate vs 2022. Taxi policy count 13k at 30 September 2023 (30 June 2023: 14k)

? Underwriting performance across the portfolio in Q3 supports expectation of an improvement in the combined operating ratio for H2 vs H1 2023. Expect combined operating ratio for 2023 at the higher end of 85% - 90% on a discounted basis in-line with previous guidance

? Post-dividend solvency capital ratio as at 30 September 2023 of 191% (30 September 2022: 163%)

? Expect to have sufficient capital to allow the Board flexibility in determining an appropriate dividend distribution at year-end in-line with our policy - an ordinary dividend payout ratio of 70% of adjusted profit after tax and a distribution of surplus capital through special dividends

Market trends

? Growth in our GWP and policy count despite price increases suggests market pricing correction has continued through Q3, with Sabre continuing to see the benefits of acting early with respect to pricing

? Claims inflation for 2023 continues at around 10%, however rate increases applied are sufficient to cover slightly higher levels of inflation and improve loss ratios towards historical norms, from which we expect to see the benefit in 2024

Full-year premium guidance raised; profitability reaffirmed

? Premium in recent months has been above expectations, therefore we increase our overall 2023 full-year gross written premium year-on-year growth expectation to 20% - 25%

? Reiterate profitability guidance provided at half-year, expect discounted combined operating ratio for the full-year 2023 at the upper end of the 85% - 90% range

? Premium growth and momentum in underwriting margin improvements will earn through in 2024, which we expect to result in further improvement in combined operating ratio in-line with previous guidance

Geoff Carter, Chief Executive Officer of Sabre, commented:

"Having stuck firmly to our 'profitability over volume' strategy through four-years of persistent market under-pricing and periods of very high inflation, we are now starting to show the benefits of our strategy as market pricing continues to correct.

We have been able to increase prices at a level to cover high on-going inflation whilst also returning anticipated profitability on written business towards our historical levels - in recent months core Motor Vehicle business has been written at an assessed sub-80% undiscounted combined operating ratio - which we have achieved at the same time as writing total GWP considerably higher than our expectations. This should contribute to continued improvement in the financial-year combined operating ratio for 2024, as business written in recent months starts to earn through and the impact of Taxi business written earlier in 2023 subsides.

It is also pleasing to see Motorcycle now performing at around the required level and Taxi performance improving as planned.

Our success so far this year is evident in the high premium levels and very strong solvency position which will allow sufficient headroom for further growth whilst allowing the Board flexibility in determining an appropriate dividend distribution at year-end in-line with our policy.

I would like to thank all our people and shareholders, who have supported Sabre through an extended and challenging market, as we look to a bright and exciting future."

Investor enquiries

01306 747 272

Sabre Insurance Group plc

investor.relations@sabre.co.uk

Geoff Carter / Adam Westwood

Media enquiries

020 7353 4200

Teneo

sabre@teneo.com

James Macey White / Eleanor Pomeroy

LEI Code: 2138006RXRQ8P8VKGV98

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFWFWAEDSEDS
Date   Source Headline
2nd Jun 20267:00 amRNSOn-market Share Buyback Programme of £5m
27th May 20269:36 amRNSDirector Declaration
21st May 202611:20 amRNSResult of AGM
21st May 20267:00 amRNSTrading Update
12th May 20261:22 pmRNSDirector/PDMR Shareholding
22nd Apr 20261:18 pmRNSDirector/PDMR Shareholding
14th Apr 20263:48 pmRNSDirector/PDMR Shareholding
13th Apr 20263:18 pmRNSDirector/PDMR Shareholding
8th Apr 20262:56 pmRNSDirector/PDMR Shareholding
8th Apr 202610:41 amRNSDirector/PDMR Shareholding
8th Apr 202610:39 amRNSDirector/PDMR Shareholding
30th Mar 202611:01 amRNSNotice of AGM
11th Mar 20261:49 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSFull-year results 2025
11th Feb 20261:27 pmRNSDirector/PDMR Shareholding
13th Jan 20263:43 pmRNSDirector/PDMR Shareholding
11th Dec 20251:29 pmRNSDirector/PDMR Shareholding
11th Nov 20251:40 pmRNSDirector/PDMR Shareholding
31st Oct 20258:00 amRNSTotal Voting Rights
23rd Oct 20259:58 amRNSDirector/PDMR Shareholding
16th Oct 20257:00 amRNSTrading Update
14th Oct 20257:49 amRNSHolding(s) in Company
13th Oct 20253:56 pmRNSDirector/PDMR Shareholding
3rd Oct 20257:00 amRNSCompletion of Buyback Programme
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20257:00 amRNSTransaction in Own Shares
30th Sep 202510:21 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20251:01 pmRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20254:52 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 202512:24 pmRNSDirector/PDMR Shareholding
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.